Capital raised by Lycia Therapeutics
1 Form D filing · first filed Jun 2026 · South San Francisco, CA
Chief Executive Officer
Signatory on Lycia Therapeutics's Form D filings · $75.0M raised across 1
Aetna Wun Trombley is on file as Chief Executive Officer at Lycia Therapeutics in South San Francisco, CA. Lycia Therapeutics has 1 Form D filing on record, $75.0M raised in total. Aetna Wun Trombley appears as a signatory on the company's filings.
LinkedIn profileA lysosomal-targeting-chimera drug discovery platform that generates bifunctional molecules which bind an extracellular target protein and shuttle it into the lysosome for degradation, plus a catalytic variant the company calls CataLYTAC.
